Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;23(11):1499-504.
doi: 10.1038/ejhg.2015.19. Epub 2015 Feb 25.

Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome

Concetta Cafiero  1 , Giuseppe Marangi  1 , Daniela Orteschi  1 , Marwan Ali  2 , Alessia Asaro  1 , Emanuela Ponzi  1 , Alice Moncada  1 , Stefania Ricciardi  1 , Marina Murdolo  1 , Giorgia Mancano  1 , Ilaria Contaldo  3 , Vincenzo Leuzzi  4 , Domenica Battaglia  3 , Eugenio Mercuri  3 , Anne M Slavotinek  2 , Marcella Zollino  1
Affiliations

Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome

Concetta Cafiero et al. Eur J Hum Genet. 2015 Nov.

Abstract

MED13L haploinsufficiency has recently been described as responsible for syndromic intellectual disability. We planned a search for causative gene variants in seven subjects with intellectual disability and overlapping dysmorphic facial features such as bulbous nasal tip, short mouth and straight eyebrows. We found two de novo frameshift variants in MED13L, consisting in single-nucleotide deletion (c.3765delC) and duplication (c.607dupT). A de novo nonsense variant (c.4420A>T) in MED13L was detected in a further subject in the course of routine whole-exome sequencing. By analyzing the clinical data of our patients along with those recently described in the literature, we confirm that there is a common, recognizable phenotype associated with MED13L haploinsufficiency, which includes intellectual disability and a distinctive facial appearance. Congenital heart diseases are found in some subjects with various degree of severity. Our observation of cleft palate, ataxia, epilepsy and childhood leukemia observed in single cases broadens the known clinical spectrum. Haploinsufficiency for MED13L should be considered in the differential diagnosis of the 1p36 microdeletion syndrome, due to overlapping dysmorphic facial features in some patients. The introduction of massive parallel-sequencing techniques into clinical practice is expected to allow for detection of other causative point variants in MED13L. Analysis of genomic data in connection with deep clinical evaluation of patients could elucidate genetic heterogeneity of the MED13L haploinsufficiency phenotype.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Facial characteristics of patients 1 (a and b), 2 (c and d) and 3 (e and f) with MED13L variants, and of patient 4 (g and h) with SYT1 variant.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. 1Curry CJ, Stevenson RE, Aughton D et al: Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet 1997; 72: 468–477. - PubMed
    1. 2Battaglia A, Carey JC: Diagnostic evaluation of developmental delay/mental retardation: an overview. Am J Med Genet C Semin Med Genet 2003; 117C: 3–14. - PubMed
    1. 3Leonard H, Wen X: The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev 2002; 8: 117–134. - PubMed
    1. 4Zahir F, Friedman JM: The impact of array genomic hybridization on mental retardation research: a review of current technologies and their clinical utility. Clin Genet 2007; 72: 271–287. - PubMed
    1. 5Asadollahi R, Oneda B, Sheth F et al: Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. Eur J Hum Genet 2013; 21: 1100–1104. - PMC - PubMed

MeSH terms

-